As of 2024-12-15, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (16.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -170.8%.
The range of the Relative Valuation is (7.27) - (24.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 4.8x - 17.3x | 11.0x |
Forward P/E multiples | 5.1x - 18.5x | 11.8x |
Fair Price | (7.27) - (24.66) | (16.28) |
Upside | -131.6% - -207.2% | -170.8% |
Date | P/E |